Sophie Ramel

Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease

Pierre‐Régis Burgel, I. Durieu, R. Chiron et al. · American Journal of Respiratory and Critical Care Medicine · 2021 · 227 citations

Real-Life Safety and Effectiveness of Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis

Pierre‐Régis Burgel, À. Munck, I. Durieu et al. · American Journal of Respiratory and Critical Care Medicine · 2019 · 127 citations

The global impact of SARS-CoV-2 in 181 people with cystic fibrosis

Elliot McClenaghan, Rebecca Cosgriff, K. Brownlee et al. · Journal of Cystic Fibrosis · 2020 · 86 citations · Full text

Global Impact, Respiratory Diseases, Covid-19 Pandemic +6

Continuous versus Intermittent Infusions of Ceftazidime for Treating Exacerbation of Cystic Fibrosis

D. Hubert, Evelyne Le Roux, Thibaud Lavrut et al. · Antimicrobial Agents and Chemotherapy · 2009 · 75 citations · Full text

Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis

Clémence Martin, Martine Reynaud‐Gaubert, Rébecca Hamidfar et al. · Journal of Cystic Fibrosis · 2022 · 63 citations

Transplantation, Advanced Lung Disease, Lung Transplant Candidates +6